ADVFN - Advanced Financial Network.
HOME» NASDAQ » A » AMGN Stock Price » AMGN Stock News

Amgen Inc. Share News

 Amgen Inc. (mm) Stock Price
AMGN Stock Price
 Amgen Inc. (mm) Stock Chart
AMGN Stock Chart
 Amgen Inc. (mm) Stock News
AMGN Stock News
 Amgen Inc. (mm) Company Information
AMGN Company Information
 Amgen Inc. (mm) Stock Trades
AMGN Stock Trades

Amgen To Buy Mustafa Nevzat For $700 Million

Biotechnology firm Amgen (AMGN) will buy a 95.6% stake in Mustafa Nevzat Pharmaceuticals for $700 million, in a move to expand its presence in Turkey and the surrounding region. The all-cash transaction has been approved by both the boards, the two companies said in a joint statement Wednesday. MN, which supplies pharmaceuticals to the hospital sector and is a major supplier of injectable medicines in Turkey, had revenue of approximately $200 million in 2011, the statement said. Amgen's focus on Turkey and the surrounding region, which are large, fast-growing, priority markets for Amgen, is a part of its international expansion strategy. Amgen established an affiliate in Turkey in 2010 and currently markets two products, with plans to develop its pipeline of clinical candidates for Turkey and other markets around the world. Order free Annual Report for Amgen, Inc. Visit http://djnewswires.ar.wilink.com/?link=AMGN or call 1-888-301-0513

Stock News for Amgen Inc. (AMGN)
DateTimeHeadline
03/26/201521:09:30Portfolio Changes For The First Quarter Of 2015
03/26/201516:01:00Cancer Survivor Joan Lunden Named 2015 Honorary Breakaway From...
03/23/201520:21:07Amgen Is The Stock Of The Week
03/23/201517:44:29This Market Could Grow 6250% in 10 Years
03/23/201515:25:55Why ImmunoGen Inc. is Soaring Higher Today
03/23/201512:25:04Why ImmunoGen Inc. is Soaring Higher Today
03/23/201512:14:41Why ImmunoGen, Inc. is Soaring Higher Today
03/23/201510:14:03This Market Could Grow 6250% in 10 Years
03/23/201509:00:00Amgen To Webcast Investor Call At the 73rd Annual Meeting of...
03/23/201507:30:40Biogen Idec shortens name; CEO says drug candidates in neurodegenerative...
03/21/201512:04:06Dividend Stocks: 2 to Avoid, 1 to Buy
03/21/201511:02:02Drug Spending Is Soaring: 3 Takeaways You Can't Miss
03/20/201509:00:00Amgen Submits Application For Investigational LDL Cholesterol-Lowering...
03/20/201507:56:19Court rejects Amgen's bid to block Neupogen biosimilar
03/20/201507:29:07The Market Has Got It Wrong - Cramer's Mad Money (3/19/15)
03/20/201506:42:59Does Esperion Have An Ace Up Its Sleeve?
03/19/201518:46:14Judge Denies Amgen's Request to Block Novartis's Biosimilar of...
03/19/201516:03:02Can This Biotech Stock Go from Good to Great?
03/18/201519:18:18How The Rushed Biosimilar Law Is Yielding Go-Slow Launches
03/18/201509:15:10Regeneron Pharmaceuticals: Some Uncertainty Near Term, But Maintaining...

Amgen Inc. and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations

ADVFNADVFN ItalyADVFN GermanyADVFN FranceADVFN BrazilADVFN JapanADVFN UKADVFN US noad